← Browse by Condition
Medical Condition
solid tumors
Total Trials
17
Recruiting Now
17
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 2
ClinicalMetric tracks all active clinical trials for solid tumors sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — solid tumors Clinical Trials
How many clinical trials are currently recruiting for solid tumors?
ClinicalMetric currently tracks 17 actively recruiting clinical trials for solid tumors, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 17. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for solid tumors?
solid tumors research spans Phase 1 (13 trials), Phase 2 (5 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a solid tumors clinical trial?
Eligibility criteria for solid tumors trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 13
Phase 2 5
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06066424 Phase 1
Recruiting
Enrollment
54 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06873555 Phase 1, Phase 2
Recruiting
Enrollment
60 pts
Location
China
Sponsor
Heronova Pharmaceuticals
NCT06710379 Phase 1
Recruiting
Enrollment
68 pts
Location
United States
Sponsor
Adcentrx Therapeutics
NCT06915753 Phase 1
Recruiting
Enrollment
100 pts
Location
United States, Canad...
Sponsor
Tyra Biosciences, Inc
NCT06764628 Phase 1, Phase 2
Recruiting
Enrollment
208 pts
Location
China
Sponsor
Suzhou Suncadia Biopharmaceuti...
NCT01775072
Recruiting
Enrollment
200 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT05471856 Phase 1
Recruiting
Enrollment
66 pts
Location
United States, Japan...
Sponsor
Boehringer Ingelheim
NCT07279428 Phase 1
Recruiting
Enrollment
33 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
NCT07274085 Phase 1
Recruiting
Enrollment
96 pts
Location
China
Sponsor
Hangzhou Zhongmei Huadong Phar...
NCT07195916 Phase 1
Recruiting
Enrollment
280 pts
Location
United States, Austr...
Sponsor
Incyte Corporation
NCT06973863 Phase 1
Recruiting
Enrollment
40 pts
Location
Australia, Taiwan
Sponsor
PharmaEngine
NCT07591155 Phase 1
Recruiting
Enrollment
22 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
NCT01166009
Recruiting
Enrollment
99,999,999 pts
Location
United States
Sponsor
Center for International Blood...
NCT07159126 Phase 1
Recruiting
Enrollment
70 pts
Location
Japan
Sponsor
Daiichi Sankyo
NCT04685226 Phase 1, Phase 2
Recruiting
Enrollment
310 pts
Location
China
Sponsor
Beijing InnoCare Pharma Tech C...
NCT03175224 Phase 2
Recruiting
Enrollment
497 pts
Location
United States, Austr...
Sponsor
Apollomics Inc.
NCT05503797 Phase 2
Recruiting
Enrollment
254 pts
Location
United States, Austr...
Sponsor
Fore Biotherapeutics
Related Conditions
ovarian cancer (1) small cell lung cancer (1) metastatic hepatocellular carcinoma (1) solid tumor adult (1) fgfr gene amplification (1) fgfr gene alterations (1) fgfr3 gene alteration (1) fgfr3 gene mutation (1) advanced solid tumors (1) fgfr4 gene mutation (1) fgfr4 gene fusions (1) fgf19 gene amplification (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology